GAMIDA CELL LTD's ticker is GMDA and the CUSIP is M47364100. A total of 14 filers reported holding GAMIDA CELL LTD in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $155,010 | -44.9% | 150,495 | +3.3% | 0.00% | – |
Q2 2023 | $281,265 | +240.4% | 145,733 | +42.9% | 0.00% | – |
Q1 2023 | $82,616 | -49.2% | 101,995 | -19.1% | 0.00% | – |
Q4 2022 | $162,679 | -27.7% | 126,108 | -10.9% | 0.00% | – |
Q3 2022 | $225,000 | +0.9% | 141,511 | +12.5% | 0.00% | – |
Q2 2022 | $223,000 | -56.9% | 125,757 | +1.1% | 0.00% | – |
Q1 2022 | $517,000 | +169.3% | 124,426 | +64.6% | 0.00% | – |
Q4 2021 | $192,000 | -25.0% | 75,602 | +15.7% | 0.00% | – |
Q3 2021 | $256,000 | -44.9% | 65,364 | -9.9% | 0.00% | – |
Q2 2021 | $465,000 | +99.6% | 72,586 | +152.1% | 0.00% | – |
Q1 2021 | $233,000 | -0.9% | 28,792 | +2.9% | 0.00% | – |
Q4 2020 | $235,000 | +126.0% | 27,992 | +12.2% | 0.00% | – |
Q3 2020 | $104,000 | -11.9% | 24,955 | -3.5% | 0.00% | – |
Q2 2020 | $118,000 | – | 25,850 | +861566.7% | 0.00% | – |
Q1 2020 | $0 | – | 3 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Consonance Capital Management LP | 3,287,745 | $27,584,000 | 2.58% |
Stonepine Capital Management, LLC | 379,470 | $3,184,000 | 2.44% |
Healthcare Value Capital, LLC | 50,000 | $420,000 | 1.42% |
BVF INC/IL | 1,343,667 | $11,273,000 | 0.44% |
Rock Springs Capital Management LP | 2,094,000 | $17,569,000 | 0.37% |
SILVERARC CAPITAL MANAGEMENT, LLC | 70,852 | $594,000 | 0.34% |
DRIEHAUS CAPITAL MANAGEMENT LLC | 2,431,795 | $20,403,000 | 0.33% |
Atom Investors LP | 217,231 | $1,823,000 | 0.18% |
MYDA Advisors LLC | 56,000 | $470,000 | 0.14% |
J. Goldman & Co LP | 314,236 | $2,636,000 | 0.13% |